Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer’s disease
- 9 September 2004
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 367 (3) , 379-383
- https://doi.org/10.1016/j.neulet.2004.06.039
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Brain‐derived neurotrophic factor genetic variants are not susceptibility factors to Alzheimer's disease in ItalyAnnals of Neurology, 2004
- The Application of Functional Genomics to Alzheimer’s DiseasePharmacogenomics, 2003
- The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal FunctionPublished by Elsevier ,2003
- Visualizing Genetic Influences on Human Brain FunctionsCell, 2003
- Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis ConsortiumJAMA, 1997
- Trail making test: normative values from 287 normal adult controlsThe Italian Journal of Neurological Sciences, 1996
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- The human BDNF gene maps between FSHB and HVBS1 at the boundary of 11p13–p14Genomics, 1992
- Italian Multicenter Study on Dementia: A Protocol for Data Collection and Clinical Diagnosis of Alzheimer's DiseaseNeuroepidemiology, 1992
- Italian multicentre study on dementia (SMID): A neuropsychological test battery for assessing Alzheimer's diseaseJournal of Psychiatric Research, 1990